Literature DB >> 18815220

Lipocalin-2-induced renal regeneration depends on cytokines.

Eugenia Vinuesa1, Anna Sola, Michaela Jung, Vicente Alfaro, Georgina Hotter.   

Abstract

This study investigated whether the renal regeneration occurring in the recovery phase of kidney ischemia-reperfusion (I/R) is mediated by endogenously generated lipocalin-2 (Lcn2). A second objective was to examine whether Lcn2-mediated cell effects could be regulated by the inflammatory cytokines in the environment through their action on Lcn2 receptors (Lcn2R and megalin). Male Swiss mice were subjected to 30 min of renal ischemia with a reperfusion period of 24 h (early reperfusion, expected time for maximum inflammation) and 96 h (late reperfusion, expected time for maximum regeneration). Different experimental groups underwent I/R, I/R with iv anti-mouse Lcn2 monoclonal antibody injected during the early/inflammatory or late/recovery phase, and I/R with proinflammatory cytokine cocktail administration (recombinant mouse IL-1beta, TNF-alpha, and IFN-gamma). Compared with control nonischemic mice, the expression of three proliferation markers (stathmin, PCNA, and Ki-67, analyzed by quantitative RT-PCR) increased significantly in the I/R-treated animals. Blockade of Lcn2 by addition of anti-Lcn2 antibody significantly decreased the expression of these three proliferation markers when administered in the late/reparative phase, but had the opposite effect when administered in the early/inflammatory phase. Proinflammatory cytokine cocktail administration reduced the proliferative effects of Lcn2, and repressed Lcn2R and megalin expression. In conclusion, endogenously generated Lcn2 induces renal cell regeneration depending on the inflammatory cytokines in kidney I/R.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815220     DOI: 10.1152/ajprenal.90250.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  11 in total

1.  Cell mediated immune responses through TLR4 prevents DMBA-induced mammary carcinogenesis in mice.

Authors:  Mohammed Naseemuddin; Aneeqa Iqbal; Tahseen H Nasti; Jennifer L Ghandhi; Akash D Kapadia; Nabiha Yusuf
Journal:  Int J Cancer       Date:  2011-06-18       Impact factor: 7.396

2.  Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model.

Authors:  Marcella Franquesa; Esther Herrero; Joan Torras; Elia Ripoll; Maria Flaquer; Montse Gomà; Nuria Lloberas; Ignacio Anegon; Josep M Cruzado; Josep M Grinyó; Immaculada Herrero-Fresneda
Journal:  Stem Cells Dev       Date:  2012-05-18       Impact factor: 3.272

3.  Differential role of lipocalin 2 during immune complex-mediated acute and chronic inflammation in mice.

Authors:  Rangaiah Shashidharamurthy; Deepa Machiah; Jesse D Aitken; Kalyani Putty; Gayathri Srinivasan; Benoit Chassaing; Charles A Parkos; Periasamy Selvaraj; Matam Vijay-Kumar
Journal:  Arthritis Rheum       Date:  2013-04

4.  Lipocalin 2 performs contrasting, location-dependent roles in APCmin tumor initiation and progression.

Authors:  P T Reilly; W L Teo; M J Low; A A Amoyo-Brion; C Dominguez-Brauer; A J Elia; T Berger; G Greicius; S Pettersson; T W Mak
Journal:  Oncogene       Date:  2012-05-21       Impact factor: 9.867

5.  Megalin/LRP2 expression is induced by peroxisome proliferator-activated receptor -alpha and -gamma: implications for PPARs' roles in renal function.

Authors:  Felipe Cabezas; Jonathan Lagos; Carlos Céspedes; Carlos P Vio; Miguel Bronfman; María-Paz Marzolo
Journal:  PLoS One       Date:  2011-02-02       Impact factor: 3.240

6.  Macrophage-derived Lipocalin-2 contributes to ischemic resistance mechanisms by protecting from renal injury.

Authors:  Michaela Jung; Bernhard Brüne; Georgina Hotter; Anna Sola
Journal:  Sci Rep       Date:  2016-02-25       Impact factor: 4.379

7.  Expression and Function of Interleukin-1β-Induced Neutrophil Gelatinase-Associated Lipocalin in Renal Tubular Cells.

Authors:  Tadayoshi Konno; Rei Nakano; Ryo Mamiya; Hisashi Tsuchiya; Taku Kitanaka; Shinichi Namba; Nanako Kitanaka; Ken Okabayashi; Takanori Narita; Hiroshi Sugiya
Journal:  PLoS One       Date:  2016-11-16       Impact factor: 3.240

8.  Lipocalin-2 expressed in innate immune cells is an endogenous inhibitor of inflammation in murine nephrotoxic serum nephritis.

Authors:  Kathrin Eller; Andrea Schroll; Miriam Banas; Alexander H Kirsch; Julia M Huber; Manfred Nairz; Sergej Skvortsov; Günter Weiss; Alexander R Rosenkranz; Igor Theurl
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

9.  Exogenous Lipocalin 2 Ameliorates Acute Rejection in a Mouse Model of Renal Transplantation.

Authors:  M I Ashraf; H G Schwelberger; K A Brendel; J Feurle; J Andrassy; K Kotsch; H Regele; J Pratschke; H T Maier; F Aigner
Journal:  Am J Transplant       Date:  2015-11-23       Impact factor: 8.086

10.  Macrophage-secreted Lipocalin-2 Promotes Regeneration of Injured Primary Murine Renal Tubular Epithelial Cells.

Authors:  Anja Urbschat; Anne-Kathrin Thiemens; Christina Mertens; Claudia Rehwald; Julia K Meier; Patrick C Baer; Michaela Jung
Journal:  Int J Mol Sci       Date:  2020-03-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.